University of São Paulo: Therapeutic vaccine against cervical cancer has promising results in trials

Researchers at the Institute of Biomedical Sciences (ICB) at USP are developing a therapeutic vaccine that, in mice, was able to eliminate tumors associated with the human papillomavirus (HPV), the main causative agent of cervical cancer. Published i

Related Keywords

United States ,Maria Soares ,Parahyba ,Brazil ,America ,Alexandre Marzag ,Bruna Porchia ,Souza Ferreira ,Intraepithelial Neoplasia ,Maricy Tacla ,Edmund Chada Baracat ,National Research Ethics Committee Conep ,World Health Organization ,Ministry Of Health ,National Cancer Institute Inca ,Ethics Committees For Research ,Institute Of Biomedical Sciences ,Vaccine Development ,International Journal Of Biological Sciences ,Division Of Gynecology ,Biomedical Sciences ,International Journal ,Biological Sciences ,Tumor Immunology ,Professor Jos ,Carlos De Souza Ferreira ,Imunotera Solu ,Luana Raposo Aps ,Maria Soares Junior ,Ethics Committees ,Human Beings ,National Research Ethics Committee ,Latin America ,National Cancer Institute ,National Immunization Program ,Unified Health System ,Cervical Intraepithelial Neoplasia ,